- 現金殖利率: 4.98%、總殖利率: 4.98%、5年平均現金配發率: 92.91%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 2.26 | 14.14 | 2.00 | 1.52 | 0.00 | 0 | 88.50 | -11.06 | 0.00 | 0 | 88.50 | -11.06 |
| 2022 (9) | 1.98 | -9.17 | 1.97 | -1.99 | 0.00 | 0 | 99.49 | 7.91 | 0.00 | 0 | 99.49 | 7.91 |
| 2021 (8) | 2.18 | 11.79 | 2.01 | 0.0 | 0.00 | 0 | 92.20 | -10.55 | 0.00 | 0 | 92.20 | -10.55 |
| 2020 (7) | 1.95 | -20.73 | 2.01 | 0.5 | 0.00 | 0 | 103.08 | 26.78 | 0.00 | 0 | 103.08 | 26.78 |
| 2019 (6) | 2.46 | 21.78 | 2.00 | 11.73 | 0.00 | 0 | 81.30 | -8.25 | 0.00 | 0 | 81.30 | -8.25 |
| 2018 (5) | 2.02 | 0 | 1.79 | 62.73 | 0.00 | 0 | 88.61 | 0 | 0.00 | 0 | 88.61 | 0 |
| 2017 (4) | -0.62 | 0 | 1.10 | 10.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | 1.13 | -26.62 | 1.00 | -50.0 | 0.00 | 0 | 88.50 | -31.86 | 0.00 | 0 | 88.50 | -31.86 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.56 | 229.41 | 115.38 | 0.60 | 122.22 | 57.89 | 0.74 | 311.11 | -44.36 |
| 24Q2 (19) | 0.17 | 1600.0 | -70.69 | 0.27 | 440.0 | -60.87 | 0.18 | 1700.0 | -83.18 |
| 24Q1 (18) | 0.01 | -99.18 | -97.96 | 0.05 | -96.03 | -90.38 | 0.01 | -99.61 | -97.96 |
| 23Q4 (17) | 1.22 | 369.23 | 134.62 | 1.26 | 231.58 | 117.24 | 2.55 | 91.73 | 15.38 |
| 23Q3 (16) | 0.26 | -55.17 | -58.73 | 0.38 | -44.93 | -45.71 | 1.33 | 24.3 | -21.3 |
| 23Q2 (15) | 0.58 | 18.37 | -15.94 | 0.69 | 32.69 | 43.75 | 1.07 | 118.37 | 0.94 |
| 23Q1 (14) | 0.49 | -5.77 | 32.43 | 0.52 | -10.34 | 52.94 | 0.49 | -77.83 | 32.43 |
| 22Q4 (13) | 0.52 | -17.46 | -40.23 | 0.58 | -17.14 | -19.44 | 2.21 | 30.77 | -9.05 |
| 22Q3 (12) | 0.63 | -8.7 | 46.51 | 0.70 | 45.83 | 14.75 | 1.69 | 59.43 | 7.64 |
| 22Q2 (11) | 0.69 | 86.49 | 46.81 | 0.48 | 41.18 | 29.73 | 1.06 | 186.49 | -7.02 |
| 22Q1 (10) | 0.37 | -57.47 | -44.78 | 0.34 | -52.78 | -45.16 | 0.37 | -84.77 | -44.78 |
| 21Q4 (9) | 0.87 | 102.33 | 163.64 | 0.72 | 18.03 | 56.52 | 2.43 | 54.78 | -3.95 |
| 21Q3 (8) | 0.43 | -8.51 | -60.19 | 0.61 | 64.86 | -34.41 | 1.57 | 37.72 | -29.91 |
| 21Q2 (7) | 0.47 | -29.85 | -26.56 | 0.37 | -40.32 | -38.33 | 1.14 | 70.15 | -0.87 |
| 21Q1 (6) | 0.67 | 103.03 | 31.37 | 0.62 | 34.78 | 21.57 | 0.67 | -73.52 | 31.37 |
| 20Q4 (5) | 0.33 | -69.44 | -41.07 | 0.46 | -50.54 | -26.98 | 2.53 | 12.95 | -10.6 |
| 20Q3 (4) | 1.08 | 68.75 | 0.0 | 0.93 | 55.0 | 0.0 | 2.24 | 94.78 | 0.0 |
| 20Q2 (3) | 0.64 | 25.49 | 0.0 | 0.60 | 17.65 | 0.0 | 1.15 | 125.49 | 0.0 |
| 20Q1 (2) | 0.51 | -8.93 | 0.0 | 0.51 | -19.05 | 0.0 | 0.51 | -81.98 | 0.0 |
| 19Q4 (1) | 0.56 | 0.0 | 0.0 | 0.63 | 0.0 | 0.0 | 2.83 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 2.97 | 25.09 | -22.11 | 31.14 | -11.26 | 10.19 | N/A | - | ||
| 2024/10 | 2.38 | -50.91 | -66.24 | 28.17 | -9.94 | 9.78 | N/A | 主係因去年同期有驗收大型儀器設備，而本月並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅減少。 | ||
| 2024/9 | 4.84 | 88.62 | 81.27 | 25.79 | 6.39 | 9.63 | 0.74 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅增加。 | ||
| 2024/8 | 2.57 | 15.23 | 5.2 | 20.95 | -2.87 | 8.43 | 0.84 | - | ||
| 2024/7 | 2.23 | -38.84 | -1.88 | 18.39 | -3.9 | 9.72 | 0.73 | - | ||
| 2024/6 | 3.64 | -5.54 | -12.6 | 16.16 | -4.17 | 9.69 | 0.69 | - | ||
| 2024/5 | 3.85 | 75.74 | 55.6 | 12.52 | -1.4 | 8.27 | 0.8 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅增加。 | ||
| 2024/4 | 2.19 | -1.39 | -1.19 | 8.67 | -15.22 | 6.09 | 1.09 | - | ||
| 2024/3 | 2.22 | 32.9 | -42.51 | 6.47 | -19.11 | 6.47 | 1.01 | - | ||
| 2024/2 | 1.67 | -35.05 | -15.67 | 4.25 | 2.78 | 7.93 | 0.83 | - | ||
| 2024/1 | 2.58 | -29.96 | 19.82 | 2.58 | 19.82 | 10.07 | 0.65 | - | ||
| 2023/12 | 3.68 | -3.55 | -4.14 | 38.77 | 30.35 | 14.53 | 0.42 | - | ||
| 2023/11 | 3.81 | -45.78 | 60.87 | 35.09 | 35.46 | 13.52 | 0.45 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅增加。 | ||
| 2023/10 | 7.04 | 163.57 | 196.19 | 31.28 | 32.9 | 12.14 | 0.5 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期大幅增加。 | ||
| 2023/9 | 2.67 | 9.47 | -27.4 | 24.24 | 14.57 | 7.38 | 1.23 | - | ||
| 2023/8 | 2.44 | 7.46 | 4.44 | 21.57 | 23.4 | 8.87 | 1.02 | - | ||
| 2023/7 | 2.27 | -45.53 | 4.93 | 19.13 | 26.32 | 8.91 | 1.02 | - | ||
| 2023/6 | 4.17 | 68.18 | 117.8 | 16.86 | 29.88 | 8.86 | 0.89 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅增加。 | ||
| 2023/5 | 2.48 | 11.59 | -12.34 | 12.7 | 14.69 | 8.56 | 0.92 | - | ||
| 2023/4 | 2.22 | -42.63 | 1.59 | 10.22 | 23.96 | 8.07 | 0.98 | - | ||
| 2023/3 | 3.87 | 94.96 | 71.47 | 8.0 | 32.02 | 8.0 | 0.86 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期月分大幅增加。 | ||
| 2023/2 | 1.98 | -7.71 | 23.28 | 4.13 | 8.63 | 7.97 | 0.87 | - | ||
| 2023/1 | 2.15 | -43.98 | -2.09 | 2.15 | -2.09 | 8.36 | 0.83 | - | ||
| 2022/12 | 3.84 | 61.86 | -19.24 | 29.74 | 21.83 | 8.59 | 0.62 | - | ||
| 2022/11 | 2.37 | -0.17 | 9.29 | 25.91 | 31.77 | 8.42 | 0.63 | - | ||
| 2022/10 | 2.38 | -35.4 | 27.73 | 23.53 | 34.55 | 8.39 | 0.63 | - | ||
| 2022/9 | 3.68 | 57.5 | 81.93 | 21.16 | 35.36 | 8.17 | 0.51 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅增加。 | ||
| 2022/8 | 2.33 | 7.97 | 60.96 | 17.48 | 28.45 | 6.41 | 0.65 | 主係因110年10月份併購富康公司後產生之綜效，使得本月營收較去年同期大幅增加。 | ||
| 2022/7 | 2.16 | 13.06 | 64.05 | 15.15 | 24.57 | 6.9 | 0.61 | 主係因110年10月份併購富康公司後產生之綜效，使得本月營收較去年同期大幅增加。 | ||
| 2022/6 | 1.91 | -32.31 | 34.83 | 12.98 | 19.77 | 6.92 | 0.7 | - | ||
| 2022/5 | 2.83 | 29.34 | 98.09 | 11.07 | 17.5 | 7.27 | 0.67 | 主係因本月受疫情影響藥品銷貨收入大幅成長，故使得本月營收較去年同期月份大幅增加。 | ||
| 2022/4 | 2.18 | -3.17 | 37.8 | 8.25 | 3.13 | 6.05 | 0.81 | - | ||
| 2022/3 | 2.26 | 40.18 | 25.7 | 6.06 | -5.44 | 6.06 | 0.7 | - | ||
| 2022/2 | 1.61 | -26.71 | -41.63 | 3.81 | -17.54 | 8.56 | 0.5 | - | ||
| 2022/1 | 2.2 | -53.79 | 18.19 | 2.2 | 18.19 | 9.12 | 0.47 | - | ||
| 2021/12 | 4.75 | 119.07 | 109.65 | 24.41 | -4.43 | 8.78 | 0.37 | 主係因本月有驗收大型儀器設備，而去年同期並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅增加。 | ||
| 2021/11 | 2.17 | 16.66 | 41.3 | 19.66 | -15.55 | 6.05 | 0.53 | - | ||
| 2021/10 | 1.86 | -7.99 | 20.43 | 17.49 | -19.56 | 5.33 | 0.6 | - | ||
| 2021/9 | 2.02 | 39.35 | -42.18 | 15.63 | -22.62 | 4.79 | 0.89 | - | ||
| 2021/8 | 1.45 | 10.04 | -17.66 | 13.61 | -18.52 | 4.19 | 1.01 | - | ||
| 2021/7 | 1.32 | -7.07 | -56.98 | 12.16 | -18.63 | 4.16 | 1.02 | 主係因去年同期有驗收大型儀器設備，而本月並無驗收大型儀器設備，故使得本月營收較去年同期月份大幅減少。 | ||
| 2021/6 | 1.42 | -0.55 | -41.92 | 10.84 | -8.73 | 4.43 | 0.57 | - | ||
| 2021/5 | 1.43 | -10.02 | 14.1 | 9.42 | -0.14 | 4.81 | 0.52 | - | ||
| 2021/4 | 1.59 | -11.68 | -39.85 | 8.0 | -2.32 | 6.14 | 0.41 | - | ||
| 2021/3 | 1.79 | -34.91 | 21.11 | 6.41 | 15.49 | 6.41 | 0.37 | - | ||
| 2021/2 | 2.76 | 48.4 | -1.95 | 4.62 | 13.44 | 6.88 | 0.34 | - | ||
| 2021/1 | 1.86 | -18.04 | 47.94 | 1.86 | 47.94 | 5.66 | 0.41 | - | ||
| 2020/12 | 2.27 | 47.65 | -24.78 | 25.55 | -13.4 | 5.35 | 0.59 | - | ||
| 2020/11 | 1.54 | -0.56 | -0.94 | 23.28 | -12.1 | 6.58 | 0.48 | - | ||
| 2020/10 | 1.54 | -55.82 | 0.48 | 21.74 | -12.8 | 6.8 | 0.46 | - | ||
| 2020/9 | 3.5 | 98.44 | 3.31 | 20.2 | -13.67 | 8.32 | 0.4 | - | ||
| 2020/8 | 1.76 | -42.51 | -37.04 | 16.7 | -16.54 | 7.27 | 0.46 | - | ||
| 2020/7 | 3.06 | 25.47 | -5.47 | 14.94 | -13.21 | 6.76 | 0.49 | - | ||
| 2020/6 | 2.44 | 95.37 | -19.9 | 11.88 | -15.01 | 6.33 | 0.65 | - | ||
| 2020/5 | 1.25 | -52.56 | -34.59 | 9.44 | -13.64 | 5.37 | 0.77 | - | ||
| 2020/4 | 2.64 | 77.83 | -2.59 | 8.19 | -9.2 | 6.93 | 0.6 | - | ||
| 2020/3 | 1.48 | -47.31 | -45.44 | 5.55 | -12.03 | 5.55 | 0.76 | - | ||
| 2020/2 | 2.81 | 123.95 | 47.31 | 4.07 | 13.22 | 7.08 | 0.6 | - | ||
| 2020/1 | 1.26 | -58.33 | -25.42 | 1.26 | -25.42 | 0.0 | N/A | - | ||
| 2019/12 | 3.01 | 94.44 | -7.57 | 29.5 | 17.66 | 0.0 | N/A | - |
